Cullinan Therapeutics Free Cash Flow (Quarterly) Analysis

Cullinan Therapeutics Inc (CGEM)

18.89 +2.22 (+13.32%) USD | NASDAQ | Apr 24, 16:00

18.88 -0.01 (-0.05%) Pre-Market: 20:00

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2020. Upgrade now.

Date	Value
December 31, 2023	-18.13M
September 30, 2023	-34.14M
June 30, 2023	-31.06M
March 31, 2023	-51.16M
December 31, 2022	-25.86M
September 30, 2022	-54.60M
June 30, 2022	-25.42M
March 31, 2022	-21.91M

Date	Value
December 31, 2021	-15.17M
September 30, 2021	-10.55M
June 30, 2021	-16.20M
March 31, 2021	-1.515M
December 31, 2020	-9.435M
September 30, 2020	-9.075M
June 30, 2020	-6.254M
March 31, 2020	-5.018M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-54.60M

Minimum

Sep 2022

-1.515M

Maximum

Mar 2021

-20.97M

Average

-17.16M

Median

Free Cash Flow (Quarterly) Benchmarks